/IQVIA%20Holdings%20Inc%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
IQVIA Holdings Inc. (IQV) is a global healthcare intelligence company that supports pharmaceutical, biotech, and medical device firms across the entire drug lifecycle, from early-stage research to commercialization. With a market capitalization of $41.28 billion, it combines large-scale healthcare data, advanced analytics, and clinical trial services to help clients develop treatments faster and make more informed decisions.
The company is ready to release its FY2026 Q1 earnings soon. Ahead of the event, analysts expect IQVIA to report a profit of $2.51 per share on a diluted basis, up 5.9% year over year from $2.37 per share in the year-ago quarter. The company has exceeded consensus estimates in three of the four trailing quarters, while missing once.